A citation-based method for searching scientific literature

Cristina Escribano-Díaz, Alexandre Orthwein, Amélie Fradet-Turcotte, Mengtan Xing, Jordan T F Young, Ján Tkáč, Michael A Cook, Adam P Rosebrock, Meagan Munro, Marella D Canny, Dongyi Xu, Daniel Durocher. Mol Cell 2013
Times Cited: 528

Shirley M H Sy, Michael S Y Huen, Junjie Chen. Proc Natl Acad Sci U S A 2009
Times Cited: 346

List of shared articles

Times cited

BRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2-RAD52.
Elodie Hatchi, Liana Goehring, Serena Landini, Konstantina Skourti-Stathaki, Derrick K DeConti, Fieda O Abderazzaq, Priyankana Banerjee, Timothy M Demers, Yaoyu E Wang, John Quackenbush,[...]. Nature 2021

Critical DNA damaging pathways in tumorigenesis.
Jake A Kloeber, Zhenkun Lou. Semin Cancer Biol 2021

Ubiquitylation in DNA double-strand break repair.
Mengfan Tang, Siting Li, Junjie Chen. DNA Repair (Amst) 2021

Making Connections: Integrative Signaling Mechanisms Coordinate DNA Break Repair in Chromatin.
Anthony Sanchez, Doohyung Lee, Dae In Kim, Kyle M Miller. Front Genet 2021

Untangling the crosstalk between BRCA1 and R-loops during DNA repair.
Marta San Martin Alonso, Sylvie M Noordermeer. Nucleic Acids Res 2021

Mechanisms of PARP inhibitor resistance in ovarian cancer.
Kari Kubalanza, Gottfried E Konecny. Curr Opin Obstet Gynecol 2020

Role of Rad51 and DNA repair in cancer: A molecular perspective.
Erik Laurini, Domenico Marson, Alice Fermeglia, Suzana Aulic, Maurizio Fermeglia, Sabrina Pricl. Pharmacol Ther 2020

The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
Madalena Tarsounas, Patrick Sung. Nat Rev Mol Cell Biol 2020

RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of BRCA1-Null Cancers.
John J Krais, Yifan Wang, Andrea J Bernhardy, Emma Clausen, Jessica A Miller, Kathy Q Cai, Clare L Scott, Neil Johnson. Cancer Res 2020

Pharmacological methods to transcriptionally modulate double-strand break DNA repair.
Alanna R Kaplan, Peter M Glazer. Int Rev Cell Mol Biol 2020

PARP inhibitor resistance: the underlying mechanisms and clinical implications.
He Li, Zhao-Yi Liu, Nayiyuan Wu, Yong-Chang Chen, Quan Cheng, Jing Wang. Mol Cancer 2020